Citations

Clear

142 citation(s) found for "Hsieh, TC".

Possible improvements in effective fill factor using X‐ray fluorescent interpixel reflectors
Hsieh, Scott S.

Mayo Clinic

Medical Physics | January 23, 2024 | Volume: 51 | Issue: 3 | Pages: 1617-1625

10.1002/mp.16944 | PMID 38259109 Get It

AbstractBackgroundThe spatial resolution of energy‐integrating diagnostic CT scanners is limited by interpixel reflectors on the detector, which optically isolate pixels but create dead space. Because the width of the reflector cannot easily be decreased, fill factor diminishes as resolution increases.PurposeWe propose loading (or mixing) a high‐Z element into the reflectors, causing the reflectors to be X‐ray fluorescent. Re‐emitted characteristic X‐rays could be detected in adjacent pixels, increasing the effective fill factor and compensating for fill factor loss with higher‐resolution detectors. The purpose of this work is to understand the physical principles of this approach and to analyze its effectiveness using Monte Carlo simulations.MethodsDetector pixels were modeled using the GEANT4 Monte Carlo package. The width of the reflector was kept constant at 0.1 mm throughout, and we considered pixel pitches between 0.5 and 1 mm. The pixelated scintillator material was gadolinium oxysulfide, 3 mm thick. The baseline reflector material was chosen to be acrylic, and varying concentrations of a high‐Z element were loaded into the material. We assumed that the optical characteristics of pixels were ideal (no absorption within pixels, perfect reflection at boundaries). The detector was irradiated uniformly with 10,000 X‐ray photons to estimate its spectral response. The figure of merit was the variance of the detector signal at zero frequency normalized to that of an ideal single‐bin photon‐counting detector with 100% fill factor. Sensitivity analyses were conducted to understand the effect of varying the high‐Z element concentration and the spectrum.ResultsInitial simulations suggested that a k‐edge near 50 keV would be ideal. Gd was therefore selected as the high‐Z material. The relative variances for a conventional energy integrating detector without Gd at 1 mm pixel pitch (81% fill factor) and 0.5 mm pixel pitch (64% fill factor) were 1.38 and 1.74, compared to 1.00 for an ideal photon counting detector, implying a 26% variance penalty for 0.5 mm pitch. When 1 g/cm3 Gd was loaded into the interpixel reflector, the relative variance improved to 1.27 and 1.43, respectively, implying that the variance penalty for including Gd together with 0.5 mm pitch is only 4%. Performance was nearly maximized at 1.0 g/cm3 of Gd, but a concentration of 0.5 g/cm3 of Gd showed most of the benefit. Improvements depend weakly on kV, with lower kV associated with higher improvements. An external anti‐scatter grid was not modeled in our simulations and would reduce the expected benefit, depending greatly on the pitch and dimensionality of the anti‐scatter grid.ConclusionsThe losses in fill factor associated with smaller pixel pitch can be reduced if Gd or a similar element could be loaded into the interpixel reflector. These improvements in noise efficiency are yet to be verified experimentally.
Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom Onset
Palade, Joanna , Alsop, Eric , Courtright-Lim, Amanda , Keuren‐Jensen, Kendall Van , Palade, Joanna , Hsieh, Michael, Whitsett, Timothy G. , Galasko, Douglas

Mayo Clinic

Cells | January 23, 2024 | Volume: 13 | Issue: 3 | Pages: 207

10.3390/cells13030207 | PMID 38334599 Get It

Alzheimer’s disease (AD), due to its multifactorial nature and complex etiology, poses challenges for research, diagnosis, and treatment, and impacts millions worldwide. To address the need for minimally invasive, repeatable measures that aid in AD diagnosis and progression monitoring, studies leveraging RNAs associated with extracellular vesicles (EVs) in human biofluids have revealed AD-associated changes. However, the validation of AD biomarkers has suffered from the collection of samples from differing points in the disease time course or a lack of confirmed AD diagnoses. Here, we integrate clinical diagnosis and postmortem pathology data to form more accurate experimental groups and use small RNA sequencing to show that EVs from plasma can serve as a potential source of RNAs that reflect disease-related changes. Importantly, we demonstrated that these changes are identifiable in the EVs of preclinical patients, years before symptom manifestation, and that machine learning models based on differentially expressed RNAs can help predict disease conversion or progression. This research offers critical insight into early disease biomarkers and underscores the significance of accounting for disease progression and pathology in human AD studies.
Combat strategies for charge sharing and pulse pileup with photon counting detectors
Iwanczyk, Jan S., Hsieh, S. S., Taguchi, Katsuyuki , Hsieh, S. S.

Mayo Clinic

2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor De | December 13, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/nssmicrtsd49126.2023.10338451 Get It

Strategies to improve the detective quantum efficiency of silicon photon counting detectors
Hsieh, Shuchen , Taguchi, Katsuyuki , Hsieh, S. S.

Mayo Clinic

2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor De | December 13, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/nssmicrtsd49126.2023.10337816 Get It

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS
Harrison, Cynthia , Biery, D. N. , Zerkalenkova, Elena , Alonso‐Saladrigues, Anna , Utley, Kaylyn, Fernandes, Sneha, Carapia, Naomi Torres, Vatsayan, Anant , Pacenta, Holly , Escherich, Gabriele , Lee, Benjamin J. , Fitzjohn, Mandi R., Larson, Daniel P. , Cuevo, Raymund S., He, Rui , Reed, Kelly, Wölfl, Matthias , Raikar, Sunil S. , Savaşan, Süreyya , Puri, Latika, Gahvari, Zhubin, Talleur, Aimee C. , Abdel‐Azim, Hisham , Chamdin, Aghiad, Provost, Marlie R. M., Mezger, Kerstin, Stevens, Alexandra M. , Hsieh, Emily M. , Duffner, Ulrich, Hoang, Chloe, Davis, Kara L. , Jacoby, Elad , Попов, А. М. , Lamble, Adam J. , Raikar, Sunil S , Zerkalenkova, Elena , Harrison, Cynthia , Lee, Benjamin J , Davis, Kara L , Silbert, Sara K. , Semchenkova, Alexandra , Aldoss, Ibrahim , Zhao, Liping , Rubinstein, Jeremy , Chang, Bill H , De Moerloose, Barbara , Kuo, Dennis J , Redell, Michele S. , Duployez, Nicolas , Dickens, David S. , Chaer, Firas El , Fabrizio, Vanessa A , Wang, Hao‐Wei , Yuan, Constance M. , Pan, Jing , Ghorashian, Sara , Rives, Susana , Shah, Nirali N

Mayo Clinic

Blood | December 1, 2023 | Volume: 142 | Issue: Supplement 1 | Pages: 4202-4202

10.1182/blood-2023-182293 Get It

Introduction: Lineage switch (LS) refers to the transformation of acute leukemia from one cell lineage to another (e.g., lymphoid (ALL) to myeloid (AML)). This rare phenomenon, distinct from treatment induced malignancy (i.e., t-AML) and mixed phenotype acute leukemia (MPAL), is increasingly being observed following cell surface antigen targeting. Given challenges in the diagnosis and treatment of LS, Project EVOLVE was developed to globally identify cases of LS following immunotherapy. Methods: A protocol and data collection form for this IRB exempt study was widely disseminated to capture deidentified LS case information across multiple centers and cancer consortia. This included collection of data from published reports of LS, with authors contacted to obtain additional information. For this analysis, LS was defined by the emergence of cell-surface markers warranting reclassification of the original leukemia as a different lineage derivation based on the immunophenotype, including cases of AML emerging alongside the original ALL. “Confirmed” LS cases included those where retention of original cytogenetic or molecular aberrations and/or the clonal immunoglobulin rearrangement patterns were verified to confirm the clonal relationship. “Suspected” LS cases included those where samples to confirm clonality marker retention could not be obtained, but the clinical presentation was consistent with LS. The term “transition” was applied when immunophenotypic shifts were transient. Cases with new cytogenetic abnormalities unrelated to the original diagnosis and compatible with t-AML were excluded. Statistical analysis was primarily descriptive. Data cut-off was July 26, 2023. Results: A total of 58 cases were identified, including 19 cases referenced in prior publications. Of the 58, 11 cases were excluded from this initial analysis, including: 4 cases of t-AML, 2 cases of T-ALL to AML, and 5 “transition” cases. Collectively, 47 cases of LS (43 “confirmed”; 4 “suspected”), spanning across 3 continents and 8 countries, were analyzed. (Fig. 1A) Cases included transition from B-ALL to AML in 36 (76.6%) and to MPAL/biphenotypic/ambiguous lineage in 11 (23.4%). Two likely had MPAL at diagnosis and a third with chronic myeloid leukemia. The median age at initial diagnosis was 8.4 years (range, 1 day-76.5 years); median age at LS presentation was 11.0 years (range 0.4-77.3 years). Twenty-three (48.9%) were male and 19 (40.4%) had prior stem cell transplant (SCT). Baseline cytogenetics showed KMT2A rearrangement in 27 (57.4%). Baseline myeloid antigen co-expression was seen in 22 of 23 patients with submitted data, but variation in degree of expression across patients and antigens was substantial. The most proximal immunotherapy prior to development of LS was CAR T-cells in 23 (48.9%) and blinatumomab in 24 (51.1%). The median time from the most proximal immunotherapy to development of LS was 1.6 months (range, 7 days-36.5 months). In 7 (29.2%) patients receiving blinatumomab, LS developed during the infusion. LS presented as isolated marrow relapse in 27 (57.4%), isolated CNS in 2 (4.3%), isolated non-CNS extramedullary disease in 3 (6.4%), combined relapse in 14 (29.8%) and unreported in 1. First line treatment for LS was chemotherapy induction in 31 (66.0%), palliative care/no therapy in 8 (17.0%), and alternative therapies in the remaining 8 (17.0%). In 35 (74.5%) patients, remission induction was the goal of first line therapy. Fifteen (31.9%) achieved a complete remission (CR) of whom 2 were treated with palliative intent. Across all patients, 8 (17.0%) are alive in remission, the longest being 4.7 years from LS diagnosis; 2 (4.3%) are alive with active LS and 37 (78.7%) died from LS, their original disease, or complications of treatment of LS (Fig 1B). For those alive in CR (n=8), 7 (87.5%) proceeded to a consolidative SCT for treatment of LS and 1 patient, an octogenarian remains in remission after AML directed therapy. Conclusions: LS is emerging as an important mechanism of immune escape following immunotherapy. Project EVOLVE provides the largest dataset of patients with LS to date. This systematic, international effort reveals substantial complexity and variability in diagnosing and managing LS. Unfortunately, outcomes following LS are grim, underscoring the critical need to identify risk factors of and optimal therapies for this leukemia transformation.
Direct energy binning for photon counting detectors: Simulation study
Hsieh, Scott S. , Taguchi, Katsuyuki

Mayo Clinic

Medical Physics | November 28, 2023 | Volume: 51 | Issue: 1 | Pages: 70-79

10.1002/mp.16841 | PMID 38011545 Get It

AbstractBackgroundPhoton counting detectors (PCDs) for x‐ray computed tomography (CT) face spectral distortion from pulse pileup and charge sharing. The photon counting scheme used by many PCDs is threshold–subtract (TS) with pulse height analysis (PHA), where each counter counts up‐crossing events when pulses exceed an energy threshold. PCD data are not Poisson‐distributed due to charge sharing and pulse pileup, but the counting statistics have never been studied yet.PurposeThe objectives of this study were (1) to propose a modified photon counting scheme, direct energy binning (DB), that is expected to be robust against pulse pileup; (2) to assess the performance of DB compared to TS; and (3) to evaluate its counting statistics.MethodsWith DB scheme, counter k starts a timer upon an up‐crossing event of energy threshold k, and adds a count only if the next higher energy threshold (k+1) was not crossed within a short time window (hence, the pulse peak belongs to the energy bin k). We used Monte Carlo (MC) simulation and assessed count‐rate curves and count‐rate‐dependent spectral imaging task performance for conventional CT imaging as well as water thickness estimation, water–bone material decomposition, and K‐edge imaging with tungsten as the K‐edge material. We also assessed count‐rate‐dependent measurement statistics such as expectation, variance, and covariance of total counts as well as energy bin outputs. The agreement with counting statistics models was also evaluated.ResultsThe DB scheme improved the count‐rate curve, that is, mean measured counts as a function of input count‐rate, and peaked with 59% higher count‐rate capability than the TS scheme (3.5 × 108 counts per second (cps)/mm2 versus 2.3 × 108 cps/mm2). The Cramér–Rao lower bounds (CRLB) of the variance of basis line integrals estimation for DB was better than those for TS by 2% for the conventional CT imaging, 30% for water–bone material decomposition, and 32% for K‐edge imaging at 1000 mA (at 7.3 × 107 cps/sub‐pixel after charge sharing). When count‐rates were lower, PCD data statistics were dominated by charge sharing: the variance of total counts and lower energy bins was larger than the mean counts; the covariance of bin data was positive and non‐zero. When count‐rates were higher, PCD data statistics were dominated by pulse pileup: the variance of data was lower than the mean; the covariance of bin data was negative. The transition between the two regimes occurred smoothly, and pulse pileup dominated the statistics ≥400 mA (when the count‐rate after charge sharing was 2.9 × 107 cps/sub‐pixel and the probability of count‐loss for DB was 37%). Both DB and TS had good agreement with Yu–Fessler's models of total counts; however, DB had a better agreement with Wang's variance and covariance models for energy bin data than TS did.ConclusionsThe proposed DB scheme had several advantages over TS. At low to moderate flux, DB could improve the resilience of PCDs to pulse pileup. Counting statistics deviated from the Poisson distribution due to charge sharing for lower count‐rate conditions and pulse pileup for higher count‐rate conditions.
First pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study
Radu, Răzvan Alexandru , Costalat, Vincent , Fahed, Robert , Ghozy, Sherief , Shaikh, Hamza , Khalife, Jane , Abdalkader, Mohamad , Klein, Piers , Nguyen, Thanh N. , Heit, Jeremy J. , Regenhardt, Robert W. , Diestro, Jose Danilo Bengzon , Cancelliere, Nicole M , Amllay, Abdelaziz , Dusart, Anne , Bellante, Flavio, Rouchaud, Aymeric , Puri, Ajit S., Dyzmann, Christian , Kan, Peter , Colasurdo, Marco , Berge, Jérôme , Barreau, Xavier , Nedelcu, Simona , Henninger, Nils , Kyheng, Maéva , Marotta, Thomas R. , Stapleton, Christopher J. , Rabinov, James D. , Dofuku, Shogo , Tan, Benjamin Yong‐Qiang , Salazar‐Marioni, Sergio , Capirossi, Carolina , Mowla, Ashkan , Tjoumakaris, Stavropoula I, Khandelwal, Priyank , Biswas, Arundhati , Clarençon, Frédéric , Elhorany, Mahmoud , Premat, Kévin , Valente, Iacopo , Filipe, João Pedro , Varela, Ricardo , Quintero‐Consuegra, Miguel , Gonzalez, Nestor R. , Möhlenbruch, Markus , Tancredi, Illario , Yedavalli, Vivek , Chervak, Lina , Aziz, Yasmin , Stracke, Christian Paul , Hecker, Constantin , Hsieh, Cheng‐Yang , Liebeskind, David S. , Alexandre, Andrea , Faizy, Tobias D. , Patel, Aman B. , Lubicz, Boris , Guenego, Adrien , Klein, Piers , Nguyen, Thanh N , Heit, Jeremy J , Sweid, Ahmad , Bellante, Flavio , Forestier, Géraud , Kühn, Anna Luisa , Marnat, Gaultier , Ota, Takahiro , Dofuku, Shogo , Yeo, Leonard Ll , Salazar-Marioni, Sergio , Jabbour, Pascal , Gonzalez, Nestor R , Möhlenbruch, Markus A , Jesser, Jessica , Aziz, Yasmin , Faizy, Tobias D , Liebeskind, David S. , Ghozy, Sherief , Diestro, Jose Danilo B , Regenhardt, Robert W , Alexandru Radu, Răzvan , Fahed, Robert , Yedavalli, Vivek S , Cancelliere, Nicole M , Rouchaud, Aymeric , Colasurdo, Marco , Hecker, Constantin , Henninger, Nils , Tan, Benjamin Yq , Alexandre, Andrea M , Mowla, Ashkan , Varela, Ricardo , Siegler, James E. , Naamani, Kareem El , Meyer, Lukas , Forestier, Géraud , Saleme, Suzana , Mounayer, Charbel , Fiehler, Jens , Kühn, Anna Luisa , Puri, Ajit S , Sibon, Igor , Martinez-Gutierrez, Juan Carlos , Sheth, Sunil A , Renieri, Leonardo , Tjoumakaris, Stavropoula , Jabbour, Pascal , Khandelwal, Priyank , Pedicelli, Alessandro , Schiphorst, Adrien ter , Harker, Pablo , Gory, Benjamin , Killer-Oberpfalzer, Monika , Griessenauer, Christoph J. , Thomas, Ajith J , Weyland, Charlotte S. , Mendes Pereira, Vitor , Dmytriw, Adam A.

Mayo Clinic

European Stroke Journal | October 27, 2023 | Volume: 9 | Issue: 1 | Pages: 114-123

10.1177/23969873231208276 | PMID 37885243 Get It

Abstract Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3) with a single pass, is a significant predictor of favorable outcomes for endovascular treatment (EVT) in large vessel occlusion stroke (LVO). However, data concerning the impact on functional outcomes and predictors of FPE in medium vessel occlusions (MeVO) are scarce. Patients and Methods: We conducted an international retrospective study on MeVO cases. Multivariable logistic modeling was used to establish independent predictors of FPE. Clinical and safety outcomes were compared between the two study groups (FPE vs non-FPE) using logistic regression models. Good outcome was defined as modified Rankin Scale 0–2 at 3 months. Results: Eight hundred thirty-six patients with a final mTICI ⩾ 2b were included in this analysis. FPE was observed in 302 patients (36.1%). In multivariable analysis, hypertension (aOR 1.55, 95% CI 1.10–2.20) and lower baseline NIHSS score (aOR 0.95, 95% CI 0.93–0.97) were independently associated with an FPE. Good outcomes were more common in the FPE versus non-FPE group (72.8% vs 52.8%), and FPE was independently associated with favorable outcome (aOR 2.20, 95% CI 1.59–3.05). 90-day mortality and intracranial hemorrhage (ICH) were significantly lower in the FPE group, 0.43 (95% CI, 0.25–0.72) and 0.55 (95% CI, 0.39–0.77), respectively. Conclusion: Over 2/3 of patients with MeVOs and FPE in our cohort had a favorable outcome at 90 days. FPE is independently associated with favorable outcomes, it may reduce the risk of any intracranial hemorrhage, and 3-month mortality.
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
Schreiber, Stefan , Rogler, Gerhard , Watanabe, Mamoru , Vermeire, Séverine , Maaser, Christian , Faes, Margaux , Hoek, Paul Van , Hsieh, Jeremy, Moerch, Ulrik, Haas, Angela de, Rudolph, Christine , Oortwijn, Alessandra , Loftus, Edward V. , Danese, Silvio , Oortwijn, Alessandra , Loftus, Edward V , Vermeire, Séverine , Danese, Silvio , Zhou, Yan

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 18, 2023 | Volume: 58 | Issue: 9 | Pages: 874-887

10.1111/apt.17674 | PMID 37718932 Get It

Summary Background Filgotinib 200 mg (FIL200) is an approved treatment for adults with moderately to severely active ulcerative colitis (UC). Aim To report integrated safety data from the phase 2b/3 SELECTION study (NCT02914522) and its ongoing long‐term extension study SELECTIONLTE (NCT02914535). Methods Safety outcomes were analysed in adults with moderately to severely active UC who received FIL200, filgotinib 100 mg (FIL100) or placebo once daily throughout the 11‐week SELECTION induction study, the 47‐week SELECTION maintenance study (if applicable) and SELECTIONLTE (if applicable). Exposure‐adjusted incidence rates (EAIRs) per 100 censored patient‐years of exposure with 95% confidence intervals were reported for treatment‐emergent adverse events (AEs). Certain AE data were presented in subgroups, including age and prior biologic exposure status. Results This interim analysis included 1348 patients representing 3326.2 patient‐years of exposure. Baseline characteristics of patients entering SELECTION were similar across treatment groups. EAIRs for serious infection, thromboembolic events and major adverse cardiovascular events (MACE) were consistently low across treatment groups. Most patients with MACE had cardiovascular risk factors. The EAIR for herpes zoster was numerically higher for FIL200 than for placebo. Infection incidences were numerically higher in biologic‐experienced than biologic‐naive patients. Higher incidences of certain AEs in patients 65 years of age or older were as expected. Four deaths occurred, including three cardiovascular deaths, none of which was considered related to filgotinib. Conclusion FIL200 and FIL100 were well tolerated with no unexpected safety signals in patients with moderately to severely active UC, regardless of previous biologic exposure or age. ClinicalTrials.gov Identifiers (NCT numbers) NCT02914522, NCT02914535.
Technical note: Exploring the detectability of coronary calcification using ultra‐high‐resolution photon‐counting‐detector CT
Chang, Shaojie , Ren, Liqiang , Tang, Shanshan , Marsh, Jeffrey F., Hsieh, Scott S. , Hsieh, Scott, McCollough, Cynthia H. , Leng, Shuai

Mayo Clinic

Medical Physics | August 31, 2023 | Volume: 50 | Issue: 11 | Pages: 6836-6843

10.1002/mp.16712 | PMID 37650788 Get It

AbstractBackgroundCoronary calcification is a strong indicator of coronary artery disease, and patients with a “zero” coronary calcification score have a much lower risk of future cardiac events than those with even small amounts of calcium. However, false‐negative (incorrect zero scores) may occur if small calcifications are missed at CT due to limited spatial resolution.PurposeTo demonstrate lower limits of detection for coronary calcification using an ultra‐high‐resolution (UHR) mode on a clinical photon‐counting‐detector CT (PCD‐CT), compared to a conventional energy‐integrating‐detector CT (EID‐CT).MethodsChicken eggshell fragments (0.4–0.8 mm) mimicking coronary calcifications were scanned on a clinical PCD‐CT (NAEOTOM Alpha) in UHR mode and a conventional EID‐CT (SOMATOM Force) with matched tube potential and radiation dose levels to the PCD‐CT. PCD‐CT images were reconstructed with a sharp kernel (Qr68) and a quantum iterative algorithm (QIR‐3). Two sets of EID‐CT images were reconstructed: routine clinical kernel (Qr36, ADMIRE‐3) and a sharper kernel (Qr54) with similar noise to PCD‐CT images. With institutional review board approval, in vivo exams performed with the PCD‐CT in UHR mode were compared against patients’ clinical EID‐CT exams. The visibility of calcifications on PCD‐CT and EID‐CT images was assessed and compared qualitatively.ResultsPCD‐CT images visualized all calcified fragments, while EID‐CT failed to detect those below 0.6 mm using a routine protocol. EID‐CT with Qr54 improved visibility but distorted boundaries. Calcifications were less visible on EID‐CT than PCD‐CT as phantom sizes increased. 0.6‐ and 0.7‐mm calcified fragments were barely visible on 35‐ and 40‐cm phantom EID‐CT images. Patient cases showed small calcifications missed on EID‐CT but detected on PCD‐CT.ConclusionAt matched radiation dose, PCD‐CT in UHR mode provided higher spatial resolution and improved the detectability of small calcified fragments for different phantom/patient sizes in comparison to EID‐CT.
Integrated Urology and Primary Care Model Improves Outcomes for Men With Testosterone Deficiency
Nguyen, Vi , Berrios, Susana E., Leonard, Austin, Byrne, Eileen, Martin, Leslie, Hsieh, Tung-Chin, Byrne, Eileen R. , Berrios, Susana , Patel, Darshan P. , Martin, Leslie, Hsieh, Tung‐Chin

Mayo Clinic

Urology Practice | August 30, 2023 | Volume: 10 | Issue: 6 | Pages: 673-678

10.1097/upj.0000000000000447 | PMID 37647136 Get It